Henry Mok

Radiation Oncology

1515 Holcombe Blvd
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Association between author specialty and reported outcomes in nonrandomized comparisons of prostatectomy versus radiation.

Association between author specialty and reported outcomes in nonrandomized comparisons of prostatectomy versus radiation.

Journal: JNCI cancer spectrum

Published: March 16, 2026

Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tract.

Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tract.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: September 24, 2025

Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.

Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 14, 2025

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.

Journal: European urology

Published: April 23, 2025

Assessment of brachytherapy-induced prostate edema on postimplant dosimetric analysis in patients treated with magnetic resonance imaging-assisted radiosurgery (MARS).

Assessment of brachytherapy-induced prostate edema on postimplant dosimetric analysis in patients treated with magnetic resonance imaging-assisted radiosurgery (MARS).

Journal: Brachytherapy

Published: April 15, 2025

Upper Urinary Tract Stereotactic Body Radiotherapy Using a 1.5 Tesla Magnetic Resonance Imaging-Guided Linear Accelerator: Workflow and Physics Considerations.

Upper Urinary Tract Stereotactic Body Radiotherapy Using a 1.5 Tesla Magnetic Resonance Imaging-Guided Linear Accelerator: Workflow and Physics Considerations.

Journal: Cancers

Published: October 24, 2024

Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer.

Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer.

Journal: Brachytherapy

Published: September 15, 2024

Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences.

Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences.

Journal: Brachytherapy

Published: July 17, 2024

Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer.

Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer.

Journal: Clinical and translational radiation oncology

Published: June 06, 2024

Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center.

Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center.

Journal: Clinical and translational radiation oncology

Published: May 17, 2024

Definitive local therapy for T4 prostate cancer associated with improved local control and survival.

Definitive local therapy for T4 prostate cancer associated with improved local control and survival.

Journal: BJU international

Published: April 14, 2023

Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center.

Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 22, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026